VAP-A and Its Binding Partner CERT Drive Biogenesis of RNA-containing Extracellular Vesicles at ER Membrane Contact Sites.

Bahnisikha Barman,Bong Hwan Sung,Evan Krystofiak,Jie Ping,Marisol Ramirez,Bryan Millis,Ryan Allen,Nripesh Prasad,Sergei Chetyrkin,M. Wade Calcutt,Kasey Vickers,James G. Patton,Qi Liu,Alissa M. Weaver
DOI: https://doi.org/10.1016/j.devcel.2022.03.012
IF: 13.417
2022-01-01
Developmental Cell
Abstract:RNA transfer via extracellular vesicles (EVs) influences cell phenotypes; however, lack of information regarding biogenesis of RNA-containing EVs has limited progress in the field. Here, we identify endoplasmic reticulum membrane contact sites (ER MCSs) as platforms for the generation of RNA-containing EVs. We identify a subpopulation of small EVs that is highly enriched in RNA and regulated by the ER MCS linker protein VAP-A. Functionally, VAP-A-regulated EVs are critical for miR-100 transfer between cells and in vivo tumor formation. Lipid analysis of VAP-A-knockdown EVs revealed reductions in the EV biogenesis lipid ceramide. Knockdown of the VAP-A-binding ceramide transfer protein CERT led to similar defects in EV RNA content. Imaging experiments revealed that VAP-A promotes luminal filling of multivesicular bodies (MVBs), CERT localizes to MVBs, and the ceramide-generating enzyme neutral sphingomyelinase 2 colocalizes with VAP-A-positive ER. We propose that ceramide transfer via VAP-A-CERT linkages drives the biogenesis of a select RNA-containing EV population.
What problem does this paper attempt to address?